Skin Cancer Insights
Discover our latest resources like blog posts, webinars, white papers, case studies and solution briefs, with insightful information on the AI-powered device that detects skin cancer.
The rural skin cancer crisis Skin cancer is the most common cancer in the U.S., yet rural patients face a compounding access crisis that delays diagnosis, drives worse outcomes, and strains limited dermatology capacity. What DermaSensor brings DermaSensor — device overview DermaSensor[TM] is the first FDA-cleared AI-powered skin cancer risk detection device designed for primary […]
Better decisions, better detection, more accurate management DermaSensor empowers physicians by providing objective, actionable risk results to aid in skin cancer detection by assessing cellular and sub-cellular features that cannot be seen visually or dermoscopically. Features Indications for use The DermaSensor™ device is indicated for evaluating skin lesions suggestive of melanoma, basal cell carcinoma, and/or […]
FDA Cleared
Introduction and Objectives Skin cancer is the most common cancer worldwide and its most common types are basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma [1,2]. One in five Americans will develop skin cancer by the age of 70 and more than two people die of skin cancer in the U.S. every hour […]
Background and Objective Access to a dermatologist for diagnosis and management of skin cancer is challenging, as around 40% of the United States population live in areas that have limited access to a dermatologist [1]. This puts primary care physicians (PCPs) in an integral role for early detection of skin cancers, as early detection of […]
Stephen P Merry, MD1; Brian McCormick, MD2; Vivien Nguyen PharmD4, Kiran Chatha, MD, MPH4; Ivana Croghan, PhD1,, David Leffell, MD3 1 Mayo Clinic, Rochester, MD; 2 Hampton Family Practice, Hampton, VA; 3 Yale School of Medicine, New Haven, CT; 4 DermaSensor Inc. FDA Cleared.Available in the United States. Background and Objective Skin cancer is by far the most common type of cancer […]
Read Now
Read Now
